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Mutations in the Gene Encoding IFT Dynein Complex
Component WDR34 Cause
Jeune Asphyxiating Thoracic Dystrophy
Miriam Schmidts,1,* Julia Vodopiutz,2,25 Sonia Christou-Savina,1,25 Claudio R. Corte´s,3,25
Aideen M. McInerney-Leo,4,25 Richard D. Emes,5,6 Heleen H. Arts,7,8,9 Beyhan Tu¨ysu¨z,10 Jason D’Silva,1
Paul J. Leo,4 Tom C. Giles,6 Machteld M. Oud,7,8,9 Jessica A. Harris,4 Marije Koopmans,11
Mhairi Marshall,4 Nursel Elc¸ioglu,12 Alma Kuechler,13 Detlef Bockenhauer,14 Anthony T. Moore,15
Louise C. Wilson,16 Andreas R. Janecke,17 Matthew E. Hurles,18 Warren Emmet,19 Brooke Gardiner,4
Berthold Streubel,20 Belinda Dopita,21 Andreas Zankl,22 Hu¨lya Kayserili,23 Peter J. Scambler,1
Matthew A. Brown,4 Philip L. Beales,1 Carol Wicking,3 UK10K, Emma L. Duncan,4,24
and Hannah M. Mitchison1,*
Bidirectional (anterograde and retrograde) motor-based intraflagellar transport (IFT) governs cargo transport and delivery processes that
are essential for primary cilia growth and maintenance and for hedgehog signaling functions. The IFT dynein-2 motor complex that
regulates ciliary retrograde protein transport contains a heavy chain dynein ATPase/motor subunit, DYNC2H1, along with other less
well functionally defined subunits. Deficiency of IFT proteins, including DYNC2H1, underlies a spectrum of skeletal ciliopathies.
Here, by using exome sequencing and a targeted next-generation sequencing panel, we identified a total of 11 mutations in WDR34
in 9 families with the clinical diagnosis of Jeune syndrome (asphyxiating thoracic dystrophy).WDR34 encodes a WD40 repeat-contain-
ing protein orthologous to Chlamydomonas FAP133, a dynein intermediate chain associated with the retrograde intraflagellar transport
motor. Three-dimensional protein modeling suggests that the identified mutations all affect residues critical for WDR34 protein-protein
interactions. We find that WDR34 concentrates around the centrioles and basal bodies in mammalian cells, also showing axonemal
staining. WDR34 coimmunoprecipitates with the dynein-1 light chain DYNLL1 in vitro, and mining of proteomics data suggests
thatWDR34 could represent a previously unrecognized link between the cytoplasmic dynein-1 and IFT dynein-2motors. Together, these
data show that WDR34 is critical for ciliary functions essential to normal development and survival, most probably as a previously
unrecognized component of the mammalian dynein-IFT machinery.Primary or sensory cilia, hair-like organelles conserved as
nonmotile monocilia on the surface of most cells of mam-
mals, birds, amphibians, and fish, are implicated in diverse
cellular signaling pathways, most prominently the hedge-
hog (Hh) pathway.1 Primary cilia extend from the cell
surface, having a microtubule-based core axoneme that
nucleates from, and is anchored by, a mother centriole-
derived basal body, with their assembly and disassembly
being tightly linked to the cell cycle.2 A microtubule- and1MolecularMedicine Unit and Birth Defect Research Centre, Institute of Child H
ment of Pediatrics and Adolescent Medicine, Medical University of Vienna, 1
Queensland, St Lucia, QLD 4072, Australia; 4The University of Queensland
Hospital, Level 7, 37 Kent Street, Woolloongabba, QLD 4102, Australia; 5Schoo
versity of Nottingham, Sutton Bonington Campus, Leicestershire LE12 5RD, U
8Nijmegen Centre for Molecular Life Sciences, 9Institute for Genetic and Me
10Department of Pediatrics, Division of Pediatric Genetics, Cerrahpasa Medical
ical Genetics, Center for Human and Clinical Genetics, Leiden University Me
Marmara University Hospital, Istanbul 34716, Turkey; 13Institut fu¨r Humangen
Germany; 14Great Ormond Street Hospital and Nephro-Urology Unit, Institut
UK; 15Moorfields Eye Hospital and UCL Institute of Ophthalmology, London E
pital, LondonWC1N 3JH, UK; 17Department of Pediatrics I, and Division of Hu
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, C
lution, UCL Genetics Institute (UGI), University College London, LondonWC1
of Vienna, 1090 Vienna, Austria; 21Department of Genetics, The Canberra H
Centre for Clinical Research, Herston, QLD 4029, Australia; 23Istanbul Medical
Turkey; 24Department of Endocrinology, James Mayne Building, Royal Brisban
25These authors contributed equally to this work
*Correspondence: miriam.schmidts.10@ucl.ac.uk (M.S.), h.mitchison@ucl.ac.u
http://dx.doi.org/10.1016/j.ajhg.2013.10.003. 2013 The Authors
This is an open-access article distributed under the terms of the Creative Comm
reproduction in any medium, provided the original author and source are cre
932 The American Journal of Human Genetics 93, 932–944, NovembATP-dependent bidirectional intraflagellar transport (IFT)
system uses motor proteins to move the molecules
required for ciliogenesis and signaling from the cell body
into cilia and back out again after use. Base-to-tip antero-
grade IFT is directed by kinesin-2 with cargos carried on
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IFT.3,4 The IFT dynein-2 motor complex contains an
ATPase/motor heavy chain dynein subunit (DYNC2H1)5
and less well functionally defined subunits.6,7 The IFT-A
and IFT-B complexes consist of at least 6 and 14 subunits,
respectively.8
Ciliary defects arising from mutations in genes that
encode ciliary proteins lead to complex developmental dis-
orders in human and other vertebrates, termed ciliopa-
thies. Human ciliopathies are genetically heterogeneous
disorders characterized by variable expression of different
disease features and clinical overlap between different dis-
ease entities. This is illustrated by the skeletal ciliopathies,
which include the short-rib polydactyly syndromes (SRPS
I–V [MIM 263530, MIM 263520, MIM 263510, MIM
269860, MIM 614091]), asphyxiating thoracic dystrophy
or Jeune syndrome (JATD [MIM 208500, MIM 611263,
MIM 613091, MIM 613819, MIM 614376]), Sensenbrenner
syndrome or cranioectodermal dysplasia (CED [MIM
218330, MIM 613610, MIM 614099, MIM 614378]),
Ellis-van Creveld syndrome (MIM 225500), and Mainzer-
Saldino syndrome (MSS [MIM 266920]).9 Skeletal cilio-
pathies are frequently caused by mutations in intraflagel-
lar transport (IFT) genes and molecular genetics has
confirmed that these are at least partially allelic disorders,
for example, SRPS III/Verma-Naumoff syndrome (MIM
263510) and JATD,10–12 Sensenbrenner syndrome and
JATD,13 and MSS and JATD.14,15 Work in animal models
such as knockout mice suggests that defective IFT leads
to impaired hedgehog signaling, which disturbs chondro-
genic and osteogenic cellular proliferation and differentia-
tion, leading to chondrodysplasia phenotypes.4,16,17
This study focused on the chondrodysplasia Jeune
syndrome to further explore the role of IFT in skeletal
development and disease. JATD is a rare autosomal-
recessive disorder with a prevalence estimated at 1 per
100,000–130,000 live births. The predominant skeletal
manifestations in affected individuals are shortened limbs
and ribs causing a reduced thoracic capacity, with occa-
sional polydactyly and brachydactyly.9,18 Although SRPS
forms are inevitably lethal perinatally because of cardiore-
spiratory failure, survival rates are 40%–80% for JATD
cases.7,19 However, affected individuals who survive may
develop extraskeletal ciliopathy features affecting the kid-
ney, eye, or more rarely the liver later in life.20,21 Defective
rhodopsin transport via the connecting cilium in retinal
photoreceptor cells is proposed as the basis for the devel-
opment of retinal dystrophy.22 The disease mechanism un-
derlying the renal phenotype, observed in approximately
20% of all JATD cases,15,19 has not been determined but
might not depend primarily on hedgehog signaling.23
Mutations in genes encoding components of the IFT sys-
tem have been implicated as causing JATD. Predominantly
skeletal phenotypes are caused by mutations in DYNC2H1
(MIM 603297)7,11,19 encoding the IFT dynein-2 retrograde
ATPase/motor heavy chain dynein,5 accounting for more
than a third of cases, and also mutations in IFT80 (MIM
611177) encoding an IFT-B anterograde transport complexThe Americancomponent.16,24 Mutations in IFT139 (TTC21B [MIM
612014]), IFT140 (MIM 614620), and WDR19 (IFT144
[MIM 608151]), encoding components of the IFT-A retro-
grade transport complex, are associated with skeletal phe-
notypes in addition to renal insufficiency.13–15,25 IFT140
mutations also appear to be frequently connected to
retinal phenotypes.14,15 In addition, we have described
mutations in both JATD and SRPS individuals in WDR60,
which encodes a WD40 domain-containing protein that
has recently been implicated in IFT in Chlamydomonas
reinhardtii and planaria.12,26
We performed whole-exome sequencing (WES) on 61
unrelated individuals with a primary diagnosis of Jeune
syndrome based on classical clinical and radiological find-
ings, mainly short ribs with small/narrow thorax and small
ilia with acetabular spurs, by using 3–5 mg of genomic DNA
and Agilent V2 or Truseq whole-exome kits as previously
described.7,12,15,27 All samples were obtained with the
approval of the UCL-ICH/Great Ormond St. Hospital (08/
H0713/82) (54 samples) and the University of Queensland
(UQ; #2011000876) (7 samples) Research Ethics Commit-
tees, with informed consent. Analysis entailed sequencing
of enriched libraries as 75 base paired-end reads (Illumina
HiSeq), removing reads that failed quality filtering via the
Illumina GA Pipeline, andmapping those reads that passed
filtering to human genome reference (UCSC Genome
Browser hg19) by using BWA v.0.5.9r16.28 Realignment
around known indels from the 1000 Genomes Pilot
study29 and recalibration of base quality scores was per-
formed with GATK 1.1.5.30 Variant calling and indepen-
dent filtering were performed with SAMtools mpileup
v.0.1.1731 and GATK UnifiedGenotyper v.1.3.31,32 merg-
ing these callsets. Exome variant profiles were filtered to
remove all variants occurring in dbSNP132, the 1000
Genomes, and NHLBI Exome project with a minor allele
frequency >0.5% for UCL samples as described7,12,15,27
by means of EVAR software tool v.0.2.2 beta, and a quality
score equivalent to a base error rate <0.1%. From the re-
maining variants, those affecting protein coding regions
(nonsynonymous changes and indels) and known splice
sites up to 15 base pairs away from the exon-intron bound-
ary were then filtered against an in-house exome database
to remove variants occurring with a frequency of >0.5%.
Remaining biallelic variants were prioritized according to
their presence in cilia proteome databases and mutation
type. Coverage of the genes known to cause JATD when
deficient was manually analyzed with Integrated Genome
Viewer (IGV), and copy-number variants were also
analyzed with the ExomeDepth program.33 WES of the
Australian samples, quality control, and filtering against
previously reported variants followed a very similar proto-
col12 with exclusion of previously reported variants from
both external and internal databases with minor allele
frequency (MAF) >0.1%; further filtering was performed
according to the observed Mendelian inheritance pattern,
functional annotation, genomic conservation, and pres-
ence in the cilia proteome databases.Journal of Human Genetics 93, 932–944, November 7, 2013 933
Table 1. Summary of Clinical Findings in WDR34 Individuals
Consanguinity
Affected
Person(s) Mutation Thorax Polydactyly Other Skeletal Features Renal Phenotype Liver Phenotype Other Remarks
Family UCL-102 (Turkish)
yes 102.5 c.1177G>A (p.Gly393Ser)
homozygous
long and narrow
thorax, short
horizontal ribs
no short long bones, trident
acetabulum with spurs
no (infant) no (infant) died aged 4 months
102.1a died
Family UCL-104 (Turkish)
no 104.4 c.1177G>A (p.Gly393Ser)
heterozygous;
c.1541_1542delCA
(p.Thr514Argfs*11);
heterozygous
short horizontal
ribs
no short long bones,
brachydactyly, mild
bowing of femora and
humeri, squared iliac
wings and irregular sciatic
notches, handlebar clavicles
no no fetus
104.1 fetus
Family UCL-57 (Turkish)
yes 57.1 c.1169C>T (p.Pro390Leu)
homozygous
short horizontal
ribs
no trident acetabulum
with spurs
bilateral nephrocalcinosis
but no cysts (infant)
no (infant) died
Family UCL-60 (Australian)
no 60.1 c.443G>T (p.Cys148Phe)
heterozygous; c.1372þ1G>A
heterozygous
narrow bell-shaped
thorax; short
horizontal ribs
with cupped ends
no rhizomelic long bone
shortening, brachydactyly,
broad thumbs and toes,
trident acetabulum with
squared hypoplastic iliae
and acetabular spurs
no (infant) no (infant);protruding
abdomen with ptosis of
liver and spleen
polyhydramnios, died
aged 46 days
Family SKDP-78 (Arab)
yes SKDP78.3 c.1339C>T (p.Arg447Trp)
homozygous
short horizontal
ribs
no short long bones
(observed at 22
and 25 weeks
gestation), trident
acetabulum with spurs
no (neonate) no (neonate) born at 34 weeks gestation
(polyhydramnios), elevated
csf spaces, foot malformation,
umbilical hernia, died aged
2 days due to respiratory
insufficiency
SKDP78.1 narrow thorax,
short ribs
no short extremities no (neonate) no (neonate) died immediately after
birth due to respiratory
insufficiency
Family UCL-101 (Turkish)
yes 101.2 c.65C>T (p.Ala22Val)
homozygous;
rs201715229, MAF 0.6%
short horizontal
ribs
no trident acetabulum
with spurs
no (infant) no (infant) died in infancy
101.1
(Continued on next page)
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The AmericanThis analysis revealed biallelic, probably damaging vari-
ants in WDR34 (MIM 613363; RefSeq accession number
NM_052844.3) in five UCL cases and in a sixth case from
Australia (SKDP-78.3), who had consanguineous parents.
None of the total of ten affected individuals in these six
families survived beyond infancy. We subsequently
analyzed an additional 52 UCL-ascertained affected indi-
viduals with the clinical diagnosis of JATD, via a targeted
next-generation sequencing (NGS) replication panel of
selected JATD candidate genes. This revealed an additional
four individuals with JATD from three families (UCL-120,
UCL-123, and UCL-130) carrying biallelic variants in
WDR34 predicted to be damaging.
The clinical details of all 14 individuals from the total of
9 JATD families harboring biallelic WDR34 mutations are
summarized in Table 1, and representative examples of
their JATD phenotypes are shown in Figure 1. Although
most individuals did not survive past the neonatal period
because of a severe respiratory phenotype, and therefore
we cannot predict whether they would have developed
renal, hepatic, or retinal involvement later in the disease
course, individual UCL-123.1 is currently 8 years of age
and has been diagnosed with rod-cone dystrophy, indi-
cating that mutations in WDR34 may lead to retinal
degeneration. A total of 11 different WDR34 variants
were found in these families (Table 2) and were validated
and confirmed to segregate appropriately within families
by Sanger sequencing (Figure S1 available online) where
DNA of other family members was available. The variants
comprised eight predicted missense changes, one frame-
shift, one nonsense, and one essential donor splice site
mutation. Prediction of the functional effects of these
mutations was performed with PolyPhen-2 and Muta-
tion Taster (Table 2). Most variants were predicted to be
damaging and deleterious to protein function by these
programs, respectively, but the homozygous c.616C>T
(p.Arg206Cys) variant (rs148543026, MAF 0.123% in the
NHLBI EVS control exome database) detected in both
affected individuals from UCL family 120 was predicted
to be benign by both programs, although it results in a
substitution at the start of the first WD40 domain of
WDR34 (Figure 2A). In keeping with previous reports
that Jeune syndrome cases are presumed hypo-
morphs,7,15 no affected individuals were found to carry
two predicted null alleles. The six homozygous variants
were restricted to consanguineous unions and probands
from an ethnic minority. Ten variants were private, and
one missense change (c.1177G>A [p.Gly393Ser]) was
shared between two families of Turkish origin. This
variant was confirmed to be absent from 100 Turkish con-
trol chromosomes and thus is unlikely to be a polymor-
phism. A homozygous missense variant identified in one
consanguineous family, UCL-101 (c.65C>T [p.Ala22Val]),
occurs with a MAF of 0.6% in NHLBI EVS and is therefore
unlikely to be deleterious to protein function by itself. We
also identified a homozygous missense variant in this
family in DYNC2H1 reported in NHLBI EVS with a similarJournal of Human Genetics 93, 932–944, November 7, 2013 935
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UCL57
A B C
D
E F
G
H I
K
J
N
UCL60
O P
L
Q
R
M
S
UCL120
T U V
W
Figure 1. Clinical Features of WDR34 Jeune Syndrome Cases
UCL102.1 (A–D), fetus UCL104.1 (E–G), UCL57.1 (H–K), UCL60.1 (L–N), SKDP78.3 (O–S), and UCL120.1 (T–W) presented with a pro-
truding abdomen and narrow thorax (A, E, H, L, O, T), short horizontal ribs (B, C, F, I, J, M, P, Q, V), and acetabular spurs (as indicated by
arrows) (D, G, K, N, R, W). Handlebar clavicles were also observed (C, F, J, M, V). Fetuses UCL104.1 (E) and SKDP78.3 (P) also showed
severely shortened femora. SKDP78.3 additionally presented with a foot malposition after birth (S). Individual UCL120.1 presented
with a narrow thorax and short ribs at birth (T, V), with indications of improvement with age (U, at 6.5 years of age).MAF of 0.6% (rs103107198). Although highly speculative,
it is possible to suggest that these mutations could act
together in trans to cause Jeune syndrome. Digenic inher-
itance has previously been proposed for Jeune syndrome
and the short-rib polydactyly syndrome associated with
DYNC2H1 mutations.34,41 The affected individuals in
families UCL-57 and UCL-101 were also heterozygous
for predicted damaging missense changes in WDR19 and
IFT140, respectively (WDR19: c.2720C>T [p.Ala907Val],
PolyPhen-2 possibly damaging [0.614], Mutation Taster
damaging [0.99]; and IFT140: c.4058C>G [p.Pro1353Arg],
PolyPhen-2 possibly damaging [0.839], Mutation Taster
disease causing [0.99]). However, the significance of
these variants for the phenotype expression is again
unknown.936 The American Journal of Human Genetics 93, 932–944, NovembWDR34 is a predicted multiple WD40 domain-contain-
ing protein and six of the eight putative missense substitu-
tions identified occur within its WD40-repeat domains,
although the other two, p.Ala22Val and p.Cys148Phe,
are in regions without domain prediction (Figure 2A).
The predicted effect of the putative mutations on
WDR34 protein structure was modeled by I-TASSER,35
which showed that the ‘‘faces’’ of the five WD40 domains
form a beta propeller site for protein-protein interactions
(Figure 2B). 3D-protein modeling predicts that four
missense substitutions (p.Pro390Leu, p.Gly393Ser,
p.Ser410Ile, and Leu436Arg) are located in close proximity
on the molecular surface of one of the beta propeller faces,
suggesting a possible role in protein-protein interaction
(Figures 2B and 2C). The missense substitutionser 7, 2013
Table 2. Details of Identified WDR34 Mutation
Consanguinity Mutation Exon Polyphen2 Mutation Taster
Protein Domain
Affected
Mutations in Other
Ciliopathy Genes
(from WES Data)
Family UCL-102 (Turkish)
yes c.1177G>A (p.Gly393Ser)
homozygous
7 probably damaging
(0.993, HumVar/Div)
disease causing
(0.9999)
mutation in WD3 no
Family UCL-104 (Turkish)
no c.1177G>A (p.Gly393Ser)
heterozygous
7 probably damaging
(0.993, HumVar/Div)
disease causing
(0.999)
mutation in WD3 no
c.1541_1542delCA
(p.Thr514Argfs*11)
heterozygous
9 - disease causing
(1.0)
mutation in WD5
Family UCL-57 (Turkish)
yes c.1169C>T (p.Pro390Leu)
homozygous
7 probably damaging
(0.926, HumVar/Div)
disease causing
(0.999)
mutation in WD3 WDR19 c.2720C>T
heterozygous
Family UCL-60 (Australian)
no c.443G>T (p.Cys148Phe)
heterozygous
1 benign (0.114,
HumVar/Div)
disease causing
(0.999)
not in specific
domain
no
c.1372þ1G>A
heterozygous
intron 8 - disease causing
(1.0)
mutation in WD4
Family SKDP-78 (Arab)
yes c.1339C>T (p.Arg447Trp)
homozygous
8 probably damaging
(0.998, HumVar/Div)
disease causing
(0.999)
mutation in WD4 no
Family UCL-101 (Turkish)
yes c.65C>T (p.Ala22Val)
homozygous; rs201715229,
MAF 0.6%
1 benign (0.3304,
HumVar);
probably damaging
(0.969, HumDiv)
polymorphism
(0.94);
rs201715229
not in specific
domain
DYNC2H1 rs103107198
(MAF 0.6%) homozygous;
IFT140 c.4058C>G
heterozygous
Family UCL-120 (German, ethnic minority)
ethnic
minority
c.616C>T (p.Arg206Cys)
homozygous
4 benign (0.001,
HumVar/Div)
polymorphism;
rs148543026;
MAF 0.123%
in NHLBI EVS
beginning of WD1
Family UCL-123 (Russian)
no c.472C>T (p.Gln158*)
heterozygous
3 - disease causing
(1.0)
not in specific
domain
c.1307A>G (p. Lys436Arg)
heterozygous
8 benign (0.005,
HumVar/Div)
disease causing
(0.973)
mutation in WD4
Family UCL-130 (Pakistani)
yes c.1229G>T (p.Ser410Ile)
homozygous
8 possibly damaging
(0.685, HumVar/Div)
disease causing
(0.999)
mutation in WD3p.Ala22Val, p.Cys148Phe, p.Arg206Cys, and p.Arg447Trp
are close by within the 3D structure (Figures 2B and 2D),
and all missense substitutions occur in this central portion
of WDR34, close to or at the surface of the protein (Figures
2C and 2D). Furthermore, the missense substitutions
affect highly conserved residues, the only exception being
p.Arg206Cys, which is not well conserved (Figure S2).
WDR34 has previously been described to inhibit the
NF-kB pathway component TAK1 in cell culture.36 Its
function during mammalian development has not been
investigated, but in zebrafish, knockdown of the wdr34
homolog dync2i1 leads to a typical ciliopathy pheno-The Americantype.37 Furthermore, WDR34 is the human homolog of
Chlamydomonas reinhardtii FAP133, an intermediate
dynein chain that forms part of the retrograde IFT-dynein
complex.6 We proceeded to investigate whether it is simi-
larly part of the IFT dynein-2 complex in mammals,
because this has not previously been determined. We first
studied its behavior in murine cells (mouse embryonic
fibroblasts, ATDC5 chondrocyte precursor cells, and inner
medullary collecting duct [IMCD3] cells), in addition to
normal human fibroblasts (Life Technologies, Sigma).
These were all cultured under standard conditions at
37C and 5% CO2 in DMEM-F12 Glutamax mediumJournal of Human Genetics 93, 932–944, November 7, 2013 937
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Figure 2. Modeling the Effect of Mutations on WDR34 Protein Structure
(A) Predicted structure of the WDR34 protein with five WD40 domains (white) and three low-complexity regions (yellow), showing the
location of the 11 mutations identified in this study.
(B) 3D-structural wild-typeWDR34model predicted by I-TASSER showing the predicted protein has a beta propeller structure formed by
the five WD40 repeat sequences. The domains are colored as follows: WD40 aa 207–246, blue; WD40 aa 255–299, red; WD40 aa 381–
421, green; WD40 aa 424–464, pink; and WD40 aa 471–511 yellow. Six missense substitutions affect residues (Arg206, Pro390, Gly393,
Ser410, Leu436, and Arg447) in theWD40 domains and one alters a residue (Cys148) that lies in close proximity within the 3D structure.
(C) WD40 domains colored as in (B), showing the location of the Pro390, Gly393, Ser410, and Leu436 residues on the molecular surface
of the beta propeller faces of the WDR34 I-TASSER model, suggesting a possible role in protein-protein interaction.
(D) Seen on the opposite side of themolecule, amino acid Arg206 is positioned directly adjacent toWD40 repeat 1 (aa positions 207–246,
blue) and Cys148 lies outside of theWD40 domains but is predicted to be close by based on the three-dimensional structure, suggesting a
possible role for these mutations in protein-protein interaction. WD40 domains colored as in (B).(Life Technologies, Invitrogen) with 10% fetal bovine
serum FBS (Life Technologies, Invitrogen), followed by a
24 hr period of serum starvation (0.2% FBS) to induce
ciliogenesis. High-resolution immunofluorescence anal-
ysis of WDR34 costained for markers of the axoneme
(acetylated tubulin) or basal bodies/centrioles (gamma
tubulin or pericentrin) revealed prominent staining of
WDR34 around the basal bodies in ciliated human fibro-
blasts (Figure 3A), with occasional axonemal staining
(Figure 3B). In non-serum-starved mouse embryonic fibro-
blasts (Figure 3C) and IMCD3 cells (Figure S3), WDR34
colocalized with the centrioles, and its staining also938 The American Journal of Human Genetics 93, 932–944, Novembextended around the centrioles in a punctate vesicular
pattern as shown by costaining with gamma tubulin dur-
ing different cell cycle stages (Figure S3). In ciliated
IMCD3 cells, WDR34 was localized to both centrioles,
often in an asymmetric pattern with more intense stain-
ing around one centriole (Figure S3). In some cells,
especially human fibroblasts, WDR34 staining was addi-
tionally observed at the nuclear membrane (Figure 3D).
To confirm that the antibody recognizes WDR34, we
preincubated the antibody with an excess of purified
recombinant myc-tagged WDR34 protein prior to immu-
nofluorescence analysis. This abrogated the staininger 7, 2013
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Figure 3. Centrosomal and Ciliary Localization of WDR34 Protein
(A and B) Serum-starved control human fibroblasts stained with polyclonal rabbit anti-WDR34 antibody (1:100, HPA0407641, Sigma)
(green), compared to mouse monoclonal antibodies for anti-acetylated tubulin (1:1000, IgG2b, clone 6-11B-1, Sigma) and anti-pericen-
trin (IgG, mAmbcam28144, Abcam) antibodies to stain cilia and basal bodies/centrioles (red), respectively, counterstained with DAPI
(blue). WDR34 localizes around the basal body (A) and is occasionally also detected at the ciliary axoneme (B).
(C) Centriolar colocalization of WDR34 (green) with gamma tubulin (1:200 IgG1 clone GTU-88, Sigma, red) in mouse embryonic fibro-
blast cells (MEFs) counterstained with DAPI (blue).
(D) Inmouse embryonic fibroblasts,WDR34 staining (green) could also be detected at thenuclearmembraneduring interphase compared
to gamma tubulin (red) and DAPI (blue), whereas general nuclear staining was observed throughout all cell cycle phases (A–D).
(E)Murine IMCD3 cells with low levels of exogenous humanWDR34-tGFP expression (TrueORFWDR34 clone fromOrigene) show local-
ization of the protein to the axoneme. For overexpression studies, cells were serum starved for 24hr beginning 24hr after transfection and
stained with anti-turboGFP (1:2,000, #AB513, Evrogen). For immunofluorescence analysis, secondary antibodies used were goat anti-
mouse IgG1Alexa Fluor 647, goat anti-mouse IgG1Alexa Fluor 568, goat anti-rabbit Alexa Fluor 488, and goat anti-rabbit Alexa Fluor 568.
Scale bars represent 5 mm in (A)–(E).
(F) WDR34 interacts with DYNLL1 in vitro, as shown by coimunoprecipitation. HEK293T cells were transfected with plasmids encoding
tGFP-tagged WDR34 (Origene) and either Flag-tagged DYNLL1 (pEF-Flag-DYNLL145) (left) or a Flag-only control plasmid (right) using
Fugene-6 reagent (Promega). Cells were lysed with nondenaturing cell lysis buffer (Cell Signaling Technology). For IP lanes (top andmid-
dle), the lysate was incubated with anti-Flag M2-beads (Sigma) and beads were washed according the manufacturers’ protocol. After blot-
ting, themembranewasblocked for1hr in5%skimmedmilk then incubatedwithanti-tGFPantibody1:500 (Origene) (top)or anti-M2-Flag
antibody (Sigma) (middle); the secondary was anHRP-coupled anti-mouse antibody (Cell Signaling Technology). The top panel shows co-
precipitationofWDR34-tGFP in theDYNLL1-Flag lanebutnot in theFlag-onlycontrol lane.Middlepanel:BothDYNLL1-FlagandFlagonly
were present in the IP reactions. Bottom panel: WDR34-tGFP input was similar for both the DYNLL1-Flag and the Flag-only reaction.
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pattern described above, with no observed colocalization
around the basal body marker pericentrin (Figure S4). In
addition, we were able to detect recombinant protein by
immunoblotting (Figure S5), although this antibody was
not capable of detecting specific bands of the predicted
size for endogenous WDR34 in cell lysates (data not
shown).
Because most of the individuals carrying mutations in
WDR34 did not survive past infancy and no samples
were available for further functional analysis, we gener-
ated stable murine chondrocyte precursor (ATDC5)
Wdr34 knockdown cell lines by using lentiviral-based
shRNAs. We produced four lentiviruses expressing
different shRNAs directed against Wdr34, in addition to
a control nonsilencing shRNA, by using the OpenBio-
systems pGIPZ mouse shRNA library: Wdr34shRNA1:
V2LMM_104963, pGIPZ RMM4431-98763533;
Wdr34shRNA2: V2LMM_74890, pGIPZ RMM4431-
98973537; Wdr34shRNA3: V3LMM_423739, pGIPZ
RMM4431-101258631; Wdr34shRNA4: V3LMM_423740,
pGIPZ RMM4431-101266083; control shRNA (nonsilenc-
ing), pGIPZ RHS4480. Murine chondrocyte precursor cells
(ATDC5) were transduced with the lentiviral particles
according to the manufacturer’s protocol at an MOI of 5
with an equivalent transduction efficiency controlled for
by GFP expression from the shRNA plasmids. Stably trans-
duced lines were generated after 3 weeks of 3 mg/ml puro-
mycin selection. Consistent with the WDR34 staining
pattern observed in other cell types, the staining in
ATDC5 cells was concentrated around the basal body
area. In two cell lines created with two of the four indepen-
dent Wdr34 shRNAs (Wdr34shRNA1 and Wdr34shRNA4),
a 70%–80% level of Wdr34 transcript knockdown was
achieved, as verified by real-time PCR (Figure S6A). High-
resolution immunofluorescence analysis with the
WDR34 antibody also revealed an apparent reduction in
staining in these two cell lines, with a specific decrease in
the peribasal staining (Figures S6B–S6E).
In contrast to the staining pattern we observed for
endogenous human and mouse WDR34 (Figures 3A–
3C), overexpression of turboGFP (tGFP)-tagged human
WDR34 in IMCD3 cells, followed by detection with an
anti-tGFP antibody, resulted in a mainly axonemal and
faint nuclear staining in low-expressing cells (Figure 3E),
with ubiquitous staining of the entire cell seen in high-
expressing cells (data not shown). In contrast to this GFP
antibody, the WDR34 antibody was not able to detect
axonemal GFP-WDR34 in low-level overexpressing cells
but detected the overexpressed protein in the highly ex-
pressing cells (data not shown), indicating that the lack
of axonemal staining observed with this antibody might
reflect an antibody sensitivity issue. Alternatively, it is
possible that the epitope recognized by this antibody is
masked in the axonemal pool of WDR34, as has been
proposed for other ciliary proteins.38 However, because
axonemal proteins are dynamically organized, it is also
possible that the axonemal localization of endogenous940 The American Journal of Human Genetics 93, 932–944, NovembWDR34 might depend on specific stimuli or activation
processes. For example, Smoothened, an integral compo-
nent of the hedgehog pathway, can normally be detected
in the cilium only after activation of Hh signaling with
the chemical agonist SAG or Hh-conditioned medium,
but overexpression leads to axonemal localization regard-
less of activation of the pathway.39,40 We did not detect
significant amounts of overexpressed GFP-tagged WDR34
at the ciliary base or around the centrioles, potentially
suggesting that the peribasal body localization might be
hampered by the GFP tag.
The localization of WDR34 around the ciliary base, as
well as around centrioles and spindle poles in dividing
cells, parallels the mainly peribasal body localization of
its Chlamydomonas homolog FAP133, with only small
amounts of FAP133 detected within the axonemal flagella
fraction.6 It is known that ciliary targeting of Chlamydomo-
nas FAP133 depends on the IFT dynein heavy chain homo-
log of human DYNC2H16 and we therefore investigated
whether WDR34 localization is changed in fibroblasts
from two affected JATD individuals previously published7
and one (more severely affected) SRPS individual carrying
biallelic DYNC2H1 mutations. Individual 001 (JATD-2 in
Schmidts et al.7) carries a homozygous missense substi-
tution in the microtubule binding stalk domain of
DYNC2H1 (c.9044A>G [p.Asp3015Gly]), whereas individ-
ual 26 (JATD-3 in Schmidts et al.7) harbors two heterozy-
gous substitutions affecting AAA domain 3 and 5 of
DYNC2H1 (c.9817C>T [p.Glu3273*] and c.7442G>A
[p.Arg2481Gln]). Individual 35 affected with SRPS harbors
a heterozygous nonsense substitution in DYNC2H1
(c.536G>A [p.Trp179*]) in the N terminus, in addition
to two missense changes (c.8726G>T [p.Cys291Phe] in
proximity of the DHC-N1 domain and c.10343T>C
[p.Cys3448Pro] affecting the 5th AAA domain). We were
not able to detect any differences in WDR34 localization
in any of theDYNC2H1-deficient cells compared to human
control fibroblasts (Figure S7). These data do not prove that
DYNC2H1 is dispensable for WDR34 targeting to the base
of the cilium, because it could be that the particular
DYNC2H1 mutations in these three individuals may not
specifically affect interactions with WDR34, in contrast
to the Chlamydomonas FAP133-null mutation, possibly re-
flecting their presumed hypomorphic nature. Further-
more, because we are not able to detect significant
amounts of endogenous axonemal WDR34 with the
commercial antibody used, it remains unclear whether
axonemal localization of WDR34 might be affected in
these DYNC2H1-deficient cells.
Reduced cilia number and/or length has previously been
reported in ciliary chondrodysplasias such as SRPS,12,13,41
but we found that the proportion of ciliated cells and cilia
length were not significantly affected in any of theWdr34-
knockdown ATDC5 lines we generated, including lines 1
and 4 that had 70%–80% reduced Wdr34 expression (Fig-
ures S8A–S8D). Staining for mitotic cells with a phosphor-
ylated-histone H3 (PH3) marker of cell proliferation waser 7, 2013
also unchanged (Figures S8E–S8H). These results suggest
that at the achieved level of knockdown, WDR34 is not
sufficient to result in a ciliogenesis defect, similarly to
results reporting no loss or malformation of cilia in the
Ift80-deficient hypomorphic Jeune syndrome mouse
model where it is considered that a low level of Ift80
expression allows ciliogenesis but does not rescue hedge-
hog signaling defects.16 Also, we have previously observed
normal cilia number and length in fibroblasts from JATD-
affected individuals with DYNC2H1 mutations but found
that retrograde IFT is impaired in those cells;7 however,
we did not observe any significant accumulation of IFT88
particles at the ciliary tip indicative of a retrograde IFT
defect in Wdr34 knockdown ATDC5 cells in comparison
to controls (Figures S8I–S8N). This suggests either that
WDR34 is not essential for retrograde IFT of IFT88, or,
more likely, that the knockdown levels were insufficient
to cause a phenotype.
To further investigate the cellular role of WDR34,
we developed a computer-based interaction network for
the protein, prompted by the findings from high-
throughput affinity capture-MS that have identified
WDR34 as a direct interaction partner of the cytoplasmic
dynein-1 light chain DYNLL1 (also known as LC8 [MIM
601562]) in humans.42 Although only the IFT dynein-2
complex enters the ciliary axoneme in mammals, both
cytoplasmic dynein-1 and IFT dynein-2 complexes are
found at the centrioles. Dynein-1 directs motor-based
movement of cytoplasmic cargos along microtubules,
which plays an important role during mitosis; mutations
in genes encoding proteins of the dynein-1 complex such
as DYNC1H1 (MIM 600112) cause severe congenital
neuronal phenotypes in humans associated with deficient
cytoplasmic microtubular transport.43 We derived data
from BioGRID v.3.2.9844 and manual input, visualizing
connections with Cytoscape v.3.0.0.,42 to generate a
model of the putative interactions of WDR34 with the
dynein-1 and dynein-2 complexes. This shows all human
dynein proteins and their neighbors (Figure S9A), as well
as interactions between the human dynein proteins and
WDR34 in first vertex degree with nodes and edges
colored to highlight WDR34 (green), DYNLL1 (red), the
other dynein proteins (orange), as well as the putative
association between WDR34 and DYNC2H1 (blue)
(Figure S9B). To provide further experimental evidence
for an interaction between WDR34 and DYNLL1 in
mammalian cells, we overexpressed both GFP-WDR34
and pEF-Flag-DYNLL145 in HEK293T cells, immunopre-
cipitated with a FLAG antibody and immunoblotted
with either GFP or FLAG antibodies to detect WDR34 or
DYNLL1, respectively. This revealed coimmunoprecipita-
tion of DYNLL1 and WDR34 (Figure 3F), confirming
that both proteins are part of the same mammalian pro-
tein complex in vitro. These results are in agreement
with previous studies on Chlamydomonas flagella proteins,
showing that the WDR34/FAP133 associates with
DYNLL1/LC8.6The AmericanThis interaction data combined with the network
described above support the proposed role of WDR34 in
the IFT dynein-2 complex, in addition to potentially link-
ing WDR34 to components of the cytoplasmic dynein-1
complex, via DYNLL1. Interestingly, another WD repeat-
containing Chlamydomonas flagellar protein, FAP163, the
homolog of WDR60,12 is a dynein intermediate chain
required for retrograde intraflagellar transport that is
closely related to FAP133.26 The staining pattern we
detected here for WDR34 is similar to that reported for
WDR60, and it is possible thatWDR34 andWDR60 belong
to the same protein complex; however, accurate character-
ization of the spatiotemporal organization of such a
complex remains to be determined. The WDR34 stain-
ing observed at the nuclear membrane in some cells
(Figure 3D) potentially links WDR34 function with the
cell cycle because components of the dynein-1 complex
are known to play a role in nuclear envelope breakdown
during mitosis.46 Although DYNLL1 is thought to be asso-
ciated with both dynein-1 and dynein-2 complexes and
mutations in the dynein-1 complex component TCTEX1
(MIM 601554) have been shown to result in a ciliary
phenotype,47 to our knowledge no mutation has been
previously identified in a gene encoding a component
associated with both the dynein-1 and IFT dynein-2 motor
complexes.
This evidence that WDR34 may have broader roles
beyond that as a component of the IFT dynein-2 retrograde
motor is consistent with previous work showing that it also
acts as inhibitor of TAK1 (MIM 601426), a component of
the NF-kB pathway in mammalian cells.36 TAK1 influences
multiple pathways such as TGF-b, p38-MAP-kinase, and
IKK, and TGF-b in turn can act as a cilia-independent
hedgehog pathway activator by directly activating Gli
transcription factors.48 Therefore, although it seems likely
thatWDR34 functions within the IFT dynein-2 and/or IFT-
A complex to influence IFT-mediated hedgehog signaling,
it is also conceivable that WDR34 influences signaling via
TGF-b independently of its ciliary role.
In summary, here we describe mutations causing Jeune
asphyxiating thoracic dystrophy in WDR34, which
encodes the homolog of the FAP133 WD40-containing
dynein intermediate chain associated with the retrograde
intraflagellar transport motor in Chlamydomonas. In this
study the mutational survey indicates that mutations in
WDR34 may account for up to 10% of all JATD cases,
which would make it the second most commonly mutated
gene after DYNC2H1 in this disease.7,19 Our evidence
based on its subcellular localization and protein interac-
tions supports a role for WDR34 as a component of the
vertebrate dynein-IFT machinery, potentially as a previ-
ously unrecognized subunit of the mammalian IFT
dynein-2 complex. We also find that WDR34 might be
involved in the dynein-1 complex not commonly associ-
ated with human ciliopathies. Together, these findings
are important for the clinical genetics setting, in addition
to implicating an additional player in the complex IFTJournal of Human Genetics 93, 932–944, November 7, 2013 941
machinery, thereby providing a better understanding of
the mammalian dynein complexes in broader cilia biology
and disease.Supplemental Data
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